Get the free mobile apps

Get the latest news from us on our apps.

Download app from Android Download app from Apple
Coverage

Leaders make urgent call to accelerate vaccination globally and in Africa

Get monthly
e-newsletter

Leaders make urgent call to accelerate vaccination globally and in Africa

World Health Organization
14 September 2021
By: 
WHO Director-General Dr Tedros Adhanom Ghebreyesus
WHO
WHO Director-General Dr Tedros Adhanom Ghebreyesus

WHO Director-General Dr Tedros Adhanom Ghebreyesus and a group of global health leaders today issued an urgent call for vaccine equity globally and in Africa in particular. The leaders stressed that the worst pandemic in the last hundred years will not end unless and until, there is genuine global cooperation on vaccine supply and access. They also reiterated the WHO’s global vaccination target for 70% of the population of all countries to be vaccinated by mid-2022. 

Dr Tedros was joined by Dr Seth Berkley, CEO Gavi, Strive Masiyima, AU Special Envoy for COVID- 19, Dr John Nkengasong, Africa CDC Director, Professor Benedict Oramah, President and Chairman of the Board of Directors, Afreximbank, Dr Vera Songwe, UN Under- Secretary- General and Executive Secretary of the Economic Commission For Africa and Dr Matshidiso Moeti, WHO Regional Director for Africa. 

The press conference followed two days of meetings among the leaders, with Richard Hatchett, Chief Executive Officer of CEPI joining the meetings as well.

Dr Tedros Adhanom Ghebreyesus: Director-General, WHO

“More than 5.7 billion doses have been administered globally, but only 2% of those have been administered in Africa.”

“This doesn’t only hurt the people of Africa, it hurts all of us. The longer vaccine inequity persists, the more the virus will keep circulating and changing, the longer the social and economic disruption will continue, and the higher the chances that more variants will emerge that render vaccines less effective.”

Strive Masiyiwa, AU Special Envoy for COVID-19 

"Vaccine sharing is good but we shouldn't have to be relying on vaccine sharing. Particularly when we can come to the table, put structures in place and say, we also want to buy."

"American taxpayers, European taxpayers, they financed some of this intellectual property and it should be for the common good. So, it is not wrong that we say there should be waivers, it was for the common good. So, we ask for this IP to be made available."

"It was a great miracle to have these vaccines, now let this miracle be available to all mankind."

“More than 5.7 billion doses have been administered globally, but only 2% of those have been administered in Africa.” “This doesn’t only hurt the people of Africa, it hurts all of us. The longer vaccine inequity persists, the more the virus will keep circulating and changing, the longer the social and economic disruption will continue, and the higher the chances that more variants will emerge that render vaccines less effective.”

Dr John Nkengasong, Africa CDC Director  

“We will not be able to achieve 60% of our population fully immunised if we do not fully explore and deploy the power of partnership, the power of cooperation, and the power of solidarity” … “We all have acknowledged now that vaccines are the only solution for us to get out of this pandemic collectively. That has to be done quickly.”

Dr Vera Songwe, UN Under- Secretary- General and Executive Secretary of the Economic Commission For Africa 

“For every one month of lockdowns in the continent cost us $29 billion of production that was lost. For [the African continent], when we say that COVID-19 is an economic issue and we need to respond to it, to be able to recover and reset our economies, it is real. And for that we need financing and we need to see how we can bring together global financial structures to ensure that we can actually respond to this crisis”.

“We know that scarcity means increased cost, and we cannot afford today as a continent that kind of scarcity.”

Professor Benedict Oramah, President and Chairman of the Board of Directors, Afreximbank

“Africa did not want to once again be at the bottom of queue in regard to vaccines because it was well known to everybody that economy recovery meant bringing the virus under control.”

“It is important that we do this for the simple reason that countries want us to make sure that we do not fail, and make it difficult for us to recover quickly.”

Dr Seth Berkley, CEO Gavi

“Today’s meeting is important, as it symbolizes the spirit of partnership between COVAX, the African Union and AVATT: Africa needs more doses and together we will get them.”

"Vaccine sharing is good but we shouldn't have to be relying on vaccine sharing. Particularly when we can come to the table, put structures in place and say, we also want to buy." "American taxpayers, European taxpayers, they financed some of this intellectual property and it should be for the common good. So, it is not wrong that we say there should be waivers, it was for the common good. So, we ask for this IP to be made available." "It was a great miracle to have these vaccines, now let thi

“We're poised to embark on the busiest period of what is the largest and most complex vaccine rollout in history. We've demonstrated that COVAX can work at scale, but it's really time for the world to get behind it.”

Dr Matshidiso Moeti, WHO Regional Director For Africa

“The question is sometimes asked do African countries have the capacity to absorb the vaccines? The simple answer is yes. The continuous challenge is that global supplies are not being shared in ways that will get the world out of this pandemic.”

“Hundreds of WHO staff are on the ground, ready to support countries to expand vaccination sites and to manage the complexities of small deliveries of a variety of vaccines“.

“What’s more, African countries have done this before – successfully implementing massive vaccination campaigns against polio, yellow fever and cholera.” 


  • WHO’s targets are to vaccinate at least 10% of the population of every country by September, at least 40% by the end of the year, and 70% globally by the middle of next year. These are the critical milestones we must reach together to end the pandemic. 
  • Almost 90% of high-income countries have now reached the 10% target, and more than 70% have reached the 40% target. Not a single low-income country has reached either target. 
  • Globally, 5.5 billion vaccine doses have been administered, but 80% have been administered in high- and upper-middle income countries.
  • High-income countries have now administered almost 100 doses for every 100 people. Meanwhile, low-income countries have only been able to administer 1.5 doses for every 100 people, due to lack of supply. 
  • The world should spare no effort to increase vaccine supply for lower-income countries: this can be done by removing all the barriers to scaling up manufacturing including waiving IP, freeing up supply chains and technology transfer. As part of these efforts, in June, WHO and COVAX partners announced the first COVID mRNA vaccine technology transfer hub, to be set up in South Africa.
  • High-income countries have promised to donate more than 1 billion doses, but less than 15% of those doses have materialised and manufacturers have promised to prioritize COVAX and low-income countries. 
  • The supply through COVAX and other sources will increase substantially in the coming months of this year. Countries need to prepare for this ramp up of available doses, for example with microplanning, expanded cold chain equipment, logistics, funding, and trained staff in place.
  • COVAX has shipped more than 236.6 million doses to 139 participants as of 6th September 2021. Some 41 participants started their first campaigns thanks to COVAX.
  • Safe and effective vaccines alone cannot solve the pandemic: Robust surveillance supported by rapid diagnostics, early clinical care and life- saving therapeutics, provided by well-trained health workers who are able to work in safe conditions. Public health and social measures are also vital to end the pandemic and accelerate global recovery.